Detalhe da pesquisa
1.
Beyond the anti-PD-1/PD-L1 era: promising role of the BTLA/HVEM axis as a future target for cancer immunotherapy.
Mol Cancer
; 22(1): 142, 2023 08 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-37649037
2.
Immunoglobulin-like transcript 2 blockade restores antitumor immune responses in glioblastoma.
Cancer Sci
; 114(1): 48-62, 2023 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-36082628
3.
BTLA dysregulation correlates with poor outcome and diminished T cell-mediated antitumor responses in chronic lymphocytic leukemia.
Cancer Immunol Immunother
; 72(7): 2529-2539, 2023 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-37041226
4.
Mechanisms of Apoptosis Resistance to NK Cell-Mediated Cytotoxicity in Cancer.
Int J Mol Sci
; 21(10)2020 May 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-32466293
5.
Chemo-Immunotherapy: A New Trend in Cancer Treatment.
Cancers (Basel)
; 15(11)2023 May 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-37296876
6.
Involvement of CD4+ and CD8+ T-lymphocytes in the modulation of nociceptive processing evoked by CCL4 in mice.
Life Sci
; 291: 120302, 2022 Feb 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-34999112
7.
Cystatin C-Based Equations Detect Hidden Kidney Disease and Poor Prognosis in Newly Diagnosed Patients with Multiple Myeloma.
Adv Hematol
; 2022: 4282226, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35469191
8.
BTLA/HVEM Axis Induces NK Cell Immunosuppression and Poor Outcome in Chronic Lymphocytic Leukemia.
Cancers (Basel)
; 13(8)2021 Apr 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-33917094
9.
LAG-3 Blockade with Relatlimab (BMS-986016) Restores Anti-Leukemic Responses in Chronic Lymphocytic Leukemia.
Cancers (Basel)
; 13(9)2021 Apr 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-33925565
10.
Mechanisms of Resistance to NK Cell Immunotherapy.
Cancers (Basel)
; 12(4)2020 Apr 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-32272610
11.
A cytofluorimetric assay to evaluate intracellular cytokine production by NK cells.
Methods Enzymol
; 631: 343-355, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-31948556
12.
Evaluation of NK cell cytotoxic activity against malignant cells by the calcein assay.
Methods Enzymol
; 631: 483-495, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-31948565
13.
Lectin-Like Transcript 1 (LLT1) Checkpoint: A Novel Independent Prognostic Factor in HPV-Negative Oropharyngeal Squamous Cell Carcinoma.
Biomedicines
; 8(12)2020 Nov 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-33255617
14.
Driver Mutations and Single Copy Number Abnormalities Identify Binet Stage A Patients with Chronic Lymphocytic Leukemia with Aggressive Progression.
J Clin Med
; 9(11)2020 Nov 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-33213108
15.
Immunosurveillance of cancer cell stress.
Cell Stress
; 3(9): 295-309, 2019 Jul 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-31535086
16.
CD107a Degranulation Assay to Evaluate Immune Cell Antitumor Activity.
Methods Mol Biol
; 1884: 119-130, 2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-30465198
17.
A Flow Cytometric NK Cell-Mediated Cytotoxicity Assay to Evaluate Anticancer Immune Responses In Vitro.
Methods Mol Biol
; 1884: 131-139, 2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-30465199
18.
NK Cells in the Treatment of Hematological Malignancies.
J Clin Med
; 8(10)2019 Sep 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-31569769
19.
The Mithralog EC-7072 Induces Chronic Lymphocytic Leukemia Cell Death by Targeting Tonic B-Cell Receptor Signaling.
Front Immunol
; 10: 2455, 2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-31681329
20.
NK Cell-Based Immunotherapy in Cancer Metastasis.
Cancers (Basel)
; 11(1)2018 Dec 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-30597841